Korean J Urol.
2015 Sep;56(9):605-606. 10.4111/kju.2015.56.9.605.
Genetic classifiers for prostate cancer: A new era on the horizon?
- Affiliations
-
- 1Department of Urology, Seoul National University Bundang Hospital, Seongnam, Korea. skhong@snubh.org
- KMID: 2344097
- DOI: http://doi.org/10.4111/kju.2015.56.9.605
Abstract
- No abstract available.
MeSH Terms
Reference
-
1. Cooperberg MR, Simko JP, Cowan JE, Reid JE, Djalilvand A, Bhatnagar S, et al. Validation of a cell-cycle progression gene panel to improve risk stratification in a contemporary prostatectomy cohort. J Clin Oncol. 2013; 31:1428–1434.2. Knezevic D, Goddard AD, Natraj N, Cherbavaz DB, Clark-Langone KM, Snable J, et al. Analytical validation of the Oncotype DX prostate cancer assay: a clinical RT-PCR assay optimized for prostate needle biopsies. BMC Genomics. 2013; 14:690.3. Den RB, Yousefi K, Trabulsi EJ, Abdollah F, Choeurng V, Feng FY, et al. Genomic classifier identifies men with adverse pathology after radical prostatectomy who benefit from adjuvant radiation therapy. J Clin Oncol. 2015; 33:944–951.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- The era of prostate-specific membrane antigen for the diagnosis and treatment of prostate cancer: A novel horizon
- Changes in Prostate Cancer Pattern according to Prostate-Specific Antigen Screening Test
- High-Grade Prostatic Intraepithelial Neoplasia
- Pathogenesis of Prostate Cancer
- Clinically relevant genetic characterization of prostate tumors: How close are we to the goal?
